Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral AntiCoagulation adherence versus usual care in patients with non-valvular Atrial Fibrillation: the MISOAC-AF trial.

[1]  G. Giannakoulas,et al.  Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design. , 2019, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[2]  G. Giannakoulas,et al.  Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation , 2019, Journal of Thrombosis and Thrombolysis.

[3]  S. Sideris,et al.  Novel therapeutic options in the prevention of atrial fibrillation. , 2018, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[4]  Mircea Cinteza,et al.  A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial , 2017, The Lancet.

[5]  Danielle E. Clarkesmith,et al.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. , 2017, The Cochrane database of systematic reviews.

[6]  A. Berghold,et al.  Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial , 2017, BMC Family Practice.

[7]  G. Caleb Alexander,et al.  Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation , 2016, Journal of the American Heart Association.

[8]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[9]  B. Koes,et al.  Open Access STUDY PROTOCOL , 2010 .